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LGI-1Autoimmune epilepsy is an isolated phenotype of autoimmune encephalitis, whichmay be suspected in patients
with unexplained adult-onset seizure disorders or resistance to antiepileptic drugs (AEDs). Antibodies against
leucine-rich glioma inactivated subunit 1 of the voltage-gated potassium channel (VGKC) complex, recently
termed anti-LGI-1 antibodies, are one of the causes of autoimmune epilepsies. Bizarre symptomswith extremely
short duration and high frequency are clues to the possible presence of autoimmune epilepsy with anti-LGI-1
antibodies. Precise diagnosis is important because autoimmune epilepsy is treatable and the prognosis can be
predicted.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Autoimmuneencephalitis is a group of syndromeswith the subacute
onset of amnesia, confusion, and often prominent seizures [1]. The spec-
trum of autoimmune encephalitis is widening. Recent retrospective
studies have shown an association between antivoltage-gated potassi-
um channel (VGKC) antibodies and the development of a new onset,
unexplained seizure disorder in patients with autoimmune limbic
encephalitis symptoms [2]. Some patients with isolated seizure
syndromes, including drug-resistant epilepsy and temporal lobe epilepsy
(TLE), have low titers of anti-VGKC-complex antibodies in their sera [2,3].
Identiﬁcation of an immune basis is important because adjunctive immu-
notherapy may improve the clinical conditions in these patients [4].
We report a case of autoimmune epilepsy with a high titer of
anti-VGKC-complex antibodies (N400 pM). Bizarre symptoms of brief
and frequent limbic seizures were the clues suggesting autoimmune
epilepsy.
2. Case report
A 53-year-old university professor was referred to our department
for investigation of seizures. He had nephrotic syndrome in childhood.. This is an open access article underTherewas nohistory of trauma, inﬂammation, infection, psychiatric dis-
ease, ormedication use. He had no relevant past medical history includ-
ing risk factors for malignancy. His family history was unremarkable.
Stereotyped paroxysmal episodes started approximately two years be-
fore presentation. In November 2009, he repeatedly experienced an ex-
tremely short (b0.5 s) and unexplained sensation like an electric shock
in the head. Thereafter, the same sensation recurred several times a day
and was triggered by startle stimulus. In December 2009, the electric
shock-like sensation increased to 20 to 30 times a day. He experienced
unexplained sadness, which he described as “transparent sadness”, for
a few minutes while watching a play. Thereafter, unexplained sadness
occurred when he listened to a certain piece of music. Listening to the
same phrase of the music induced the same unexplained sadness. He
avoided listening to music. In January 2010, he had a feeling of falling
and sensed the odor of burned rubber at the same time. Although the
feeling of falling and the sensing of the odor of burned rubber disap-
peared after only one day, the electric shock-like sensation continued.
He experienced a hot sensation in his lower left arm and lower leg
momentarily, followed by pressure behind his left ear and sharp ringing
and fullness in the left ear 10 to 20 times a day. He visited several med-
ical and psychiatric departments, but the cause could not be identiﬁed.
He consulted an epilepsy specialist in a hospital. Epilepsy was
suspected, although an electroencephalogram (EEG) showed no epilep-
tic discharge. Treatment with 300 mg of carbamazepine (CBZ) wasthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lower left arm and lower leg disappeared. Because of adverse reactions,
CBZ was discontinued, and treatment was switched to zonisamide
(ZNS). The electric shock-like sensation recurred 20 to 30 times a day.
MRI showed no abnormality. In June, water dribbled from the right cor-
ner of his mouth while drinking. On the next day (June 24 X−, he had
twitching in the right corner of his mouth for a few seconds, which
was triggered by eating. Zonisamide was discontinued, but twitching
continued. In July, he bit the right edge of his tongue during sleeping.
After starting lamotrigine (LTG) and clonazepam (CZP), the electric
shock-like sensation and twitching in the right mouth corner disap-
peared. In September, while on business travel, hewas short of medica-
tion, and the electric shock-like sensations recurred. In January 2011,
LTG was discontinued because of drowsiness, and treatment was
switched to levetiracetam (LEV). The electric shock-like sensations re-
curred and increased to 10 times a day. Adding phenytoin (PHT) was
not effective. He had a tactile sensation starting from the ﬁngers on
his right hand and spreading to the shoulder, which lasted a few sec-
onds. He saw a bolt of lightning with jagged edges several times. In
April, while he was traveling on a short-distance train, a generalized
convulsion occurred when he was awakened by the alarm clock that
he set on his cellular phone. He sustained a compression fracture of
the lumbar spine as a result of the seizure. The tactile sensation disap-
peared after the generalized convulsion.
In June 2011, he was referred to our hospital. General and physical
neurological examinations were unremarkable. He was alert, oriented,
and highly intelligent. His Mini-Mental State Examination score was
30 out of 30. Although he had several bizarre symptoms that lasted
very short durations, all the symptomswere repetitive and stereotyped,
and epileptic seizureswere suspected. Intraindividual seizure variability
and unusually high seizure frequency observed in this patient suggested
autoimmune epilepsy.
Full blood workup included routine tests to assess electrolytes, liver
and renal function, vitamins B1 and B12, and autoimmune-related anti-
bodies. All the test results were within normal ranges. Cerebrospinal
ﬂuid (CSF) examination showed no abnormality. The EEG showed no
epileptiform discharges or slow waves (Fig. 1). A magnetic resonance
imaging (MRI) (3T) scan was normal. 2-Deoxy-2-[18F] ﬂuoro-d-
glucose (18F-FDG) positron emission tomography/computed tomogra-
phy (FDG-PET/CT) of the brain and body showed no hyper- or
hypometabolism (Fig. 2). Although therewere no other features to sup-
port an autoimmune etiology, we examined autoantibodies including
anti-VGKC complex antibodies and intracellular autoantibodiesaT
mT
pT
Fig. 1. Interictal EEG.The EEG shows epil(anti-Hu, Yo, Ri, Ma2/Ta, and amphiphysin). Serum anti-VGKC complex
antibodies were elevated to 2493 pM (normal: b100 pM). The target
antigen of VGKC complex antibodies was LGI-1.
Since the patient had no other subjective symptoms includingmem-
ory impairment, he was observed without initiating immunotherapy.
Occult cancer was excluded with whole body FDG-PET/CT.
In November 2011, he became seizure-free. During follow-up over
one year, serum concentrations of anti-VGKC complex antibodies de-
clined (768 pM), and the patient remained seizure-free with nomemo-
ry impairment. In August 2014, anti-VGKC complex antibodies became
negative. He became seizure free without antiepileptic drugs.
3. Discussion
Autoimmune encephalitis is characterized by seizures, memory
disturbance, and/or psychiatric symptoms with or without inﬂamma-
tion revealed by CSF examination and/or MRI. In contrast to the
encephalitic-type phenotype of autoimmune encephalitis, the new con-
cept of autoimmune epilepsy is an isolated phenotype of autoimmune
encephalitis that lacks a typical “limbic encephalitis” phenotype and
resistance to antiepileptic drugs [5]. Recent case series have reported
neuronal autoantibodies in approximately 10% of patients whohave ep-
ilepsy without cognitive or psychiatric features [6]. Normal laboratory
and imaging ﬁndings (particularly normal CSF analysis and MRI) do
not exclude autoimmune encephalitis. Prompt diagnosis and treatment
with immunosuppressive therapies improve or even reverse symptoms.
If left untreated, retrospective case series show that these conditions
can lead to irreversible cognitive deﬁcits, ongoing seizures, and death
[7–9]. Bien and Elger suggested that limbic encephalitis should be
considered a differential diagnosis in any adult patient with newly de-
veloped temporal lobe epilepsy and/or a rather quickly progressing
amnestic disturbance [10]. Toledano et al. proposed valuable clinical
clues to diagnose autoimmune epilepsy: intraindividual seizure vari-
ability or multifocality, an unusually high seizure frequency, antiepilep-
tic drug (AED) resistance, subacute onset, personal or family history of
autoimmunity, and recent or past history of neoplasia [11]. Our case
manifested multifocal seizure types. We suspect that the electrical
shock-like sensation in the head was a cephalic aura originated
from the mesial temporal lobe, although the semiology is atypical for
temporal lobe epilepsy. Sadness triggered by speciﬁc music probably
originated from the amygdala and the odor of burned rubber from the
uncus. In addition to the temporal lobe seizures, he had other types of
seizures including mouth twitching, hot sensation, tactile sensation,1 sec
50µV
eptiform discharges or slow waves.
Fig. 2. Imaging studies. A: Brain MRI with ﬂuid-attenuated inversion-recovery (FLAIR) sequence, transaxial view. B: Brain MRI with FLAIR sequence, transcoronal view. C: Brain 18F-FDG
PET/CT, transaxial view. D: Brain 18F-FDG PET/CT, transcoronal view. Brain images (A, B, C, and D) show no abnormalities. E: Whole body 18F-FDG PET/CT shows no abnormal uptake and
excluded underlying paraneoplastic syndrome.
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originated from the extratemporal lobes. The seizures were frequent
and resistant to AEDs. Extremely short duration of seizures was charac-
teristic for this patient, although it was not reported in previous papers
[7–9,11]. The frequent and short seizures (FSS) of our case resembles
faciobrachial dystonic seizures (FBDS). Faciobrachial dystonic seizures
are multiple, brief (b3 s) episodes of simultaneous facial grimacing
and arm dystonia with a high frequency of attacks. Faciobrachial dys-
tonic seizures are highly speciﬁc for anti-LGI-1 limbic encephalitis
and are important for its recognition and diagnosis [12]. Our case
report suggests that frequent and short seizures might be an impor-
tant feature of autoimmune epilepsy associated with anti-LGI-1
antibodies.
In our patient, symptoms disappeared completely without immuno-
therapy and underwent spontaneous remission. Irani et al. reported
that FBDS often preceded the cognitive impairment observed in anti-
VGKC-complex antibody-associated limbic encephalitis [13]. Immuno-
therapy shortened the time to recovery and might prevent subsequent
development of cognitive impairment [13]. A few cases of anti-VGKC
antibody-associated limbic encephalitis that improved without immu-
nosuppressive therapy have been reported [14–16]. Butler et al. report-
ed that patients with VGKC-associated limbic encephalitis often
recovered substantially with immunotherapy despite broad cognitive
dysfunction in the acute phase but might have residual permanent an-
terograde amnesia [17]. Our case showed no cognitive dysfunction
and became seizure-free with LTG, although his seizures might
have improved earlier with immunotherapy than without immuno-
therapy. This case demonstrates that high titers of anti-VGKC
complex antibodies are not always related to a severe, progressive
clinical course.
Autoimmune epilepsy is one of the epilepsies that improves with
immunotherapy. Physicians should pay attention to clinical clues such
as subacute onset, intraindividual seizure variability or multifocality,
AED resistance, personal or family history of autoimmunity, and recent
or past history of neoplasia. In addition, FSSmight be additional features
in autoimmune epilepsy associated with anti-LGI-1 antibodies.
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